WealthPLAN Partners, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 132 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
WealthPLAN Partners, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$3,000
-57.1%
14,4350.0%0.00%
Q4 2021$7,000
-53.3%
14,4350.0%0.00%
-100.0%
Q3 2021$15,000
-28.6%
14,4350.0%0.00%0.0%
Q2 2021$21,000
-25.0%
14,4350.0%0.00%
-50.0%
Q1 2021$28,0000.0%14,4350.0%0.00%0.0%
Q4 2020$28,000
+133.3%
14,4350.0%0.00%
+100.0%
Q3 2020$12,0000.0%14,4350.0%0.00%0.0%
Q2 2020$12,000
+50.0%
14,4350.0%0.00%0.0%
Q1 2020$8,000
-57.9%
14,435
-51.0%
0.00%
-50.0%
Q4 2019$19,00029,4350.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Shilanski & Associates, Inc. 937,237$57,0000.02%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$57,0000.02%
CVA Family Office, LLC 1,137,920$69,0000.02%
Cypress Capital Management LLC (WY) 140,925$9,0000.01%
Helen Stephens Group, LLC 117,222$7,0000.01%
COURIER CAPITAL LLC 540,056$33,0000.00%
NORTHCAPE WEALTH MANAGEMENT, LLC 98,000$6,0000.00%
Newbridge Financial Services Group, Inc. 10,000$1,0000.00%
Western Wealth Management, LLC 352,950$11,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 606,800$37,0000.00%
View complete list of AMPIO PHARMACEUTICALS INC shareholders